期刊文献+

Generation of the regulatory protein rtTA transgenic mice 被引量:7

Generation of the regulatory protein rtTA transgenic mice
下载PDF
导出
摘要 AIM: To translate Tet-on system into a conditional mouse model, in which hepatitis B or C virus (HBV or HCV) gene could be spatiotemporally expressed to overcome 'immune tolerance' formed during the embryonic development and 'immune escape' against hepatitis virus antigen(s), an effector mouse, carrying the reverse tetracycline-responsive transcriptional activator (rtTA) gene under the tight control of liver-specific human apoE promoter, is required to be generated. METHODS: To address this end, rtTA fragment amplified by PCR was effectively inserted into the vector of pLiv.7 containing apoE promoter to create the rtTA expressing vector, I.e., pApoE-rtTA. ApoE-rtTA transgenic fragment (-6.9 kb) released from pApoE-rtTA was transferred into mice by pronucleus injection, followed by obtaining one transgene (+) founder animal from microinjection through PCR and Southern blot analysis.RESULTS: rtTA transgene which could be transmitted to subsequent generation (F1) derived from founder was expressed in a liver-specific fashion. CONCLUSION: Taken together, these findings demonstrate that rtTA transgenic mice, in which rtTA expression is appropriately targeted to the murine liver, are successfully produced, which lays a solid foundation to 'off-on-off' regulate expression of target gene (s) (e.g., HBV and/or HCV) in transgenic mice mediated by Tet-on system. AIM: To translate Tet-on system into a conditional mouse model, in which hepatitis B or C virus (HBV or HCV) gene could be spatiotemporally expressed to overcome 'immune tolerance' formed during the embryonic development and 'immune escape' against hepatitis virus antigen(s), an effector mouse, carrying the reverse tetracycline-responsive transcriptional activator (rtTA) gene under the tight control of liver-specific human apoE promoter, is required to be generated. METHODS: To address this end, rtTA fragment amplified by PCR was effectively inserted into the vector of pLiv.7 containing apoE promoter to create the rtTA expressing vector, i.e., pApoE-rtTA. ApoE-rtTA transgenic fragment (-6.9 kb) released from pApoE-rtTA was transferred into mice by pronucleus injection, followed by obtaining one transgene (+) founder animal from microinjection through PCR and Southern blot analysis. RESULTS: rtTA transgene which could be transmitted to subsequent generation (F1) derived from founder was expressed in a liver-specific fashion. CONCLUSION: Taken together, these findings demonstrate that rtTA transgenic mice, in which rtTA expression is appropriately targeted to the murine liver, are successfully produced, which lays a solid foundation to 'off-on-off' regulate expression of target gene (s) (e.g., HBV and/or HCV) in transgenic mice mediated by Tet-on system.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第19期2885-2891,共7页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China,No. 30271177 and No. 39870676 Guangdong Province Natural Science Foundation of China, No. 021903 Postdoctoral Fellowship Foundation of China
关键词 Hepatitis virus Tet-on system Transgenic mice Liver-specific human apoE promoter rtTA蛋白质 小鼠 动物实验 丙型肝炎病毒 乙型肝炎病毒
  • 相关文献

参考文献37

  • 1Moradpour D, Cerny A, Heim MH, Blum HE. Hepatitis C:an update. Swiss Med Wkly 2001; 131:291-298.
  • 2Rosenberg S. Recent advances in the molecular biology of hepatitis C virus. J Mol Biol 2001; 313:451-464.
  • 3Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 1980; 77: 7380-7384.
  • 4Akbar SK, Onji M. Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection. Int J Exp Pathol 1998; 79:279-291.
  • 5Feitelson MA, Larkin JD. New animal models of hepatitis B and C. ILAR J 2001; 4:127-138.
  • 6Koike K. Hepatocarcinogenesis in hepatitis viral infection:lessons from transgenic mouse studies. J Gastroenterol 2002;37(Suppl 1)- 55-64.
  • 7Milich DR. Transgenic technology and the study of hepatitis viruses: a review of what we have learned. Can J Gastroenterol 2000; 14:781-787.
  • 8Fausto N. A mouse model for hepatitis C virus infection? Nat Med 2001; 7:890-891.
  • 9Kawamura T, Furusaka A, Koziel MJ, Chung RT, Wang TC,Schmidt EV, Liang TJ. Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 1997; 25:1014-1021.
  • 10Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T,Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K.The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4:1065-1067.

同被引文献19

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部